Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
Resource Type
Article
Authors
Weber, Jeffrey S ; Carlino, Matteo S ; Khattak, Adnan ; Meniawy, Tarek ; Ansstas, George ; Taylor, Matthew H ; Kim, Kevin B ; McKean, Meredith ; Long, Georgina V ; Sullivan, Ryan J ; Faries, Mark ; Tran, Thuy T ; Cowey, C Lance ; Pecora, Andrew ; Shaheen, Montaser ; Segar, Jennifer ; Medina, Theresa ; Atkinson, Victoria ; Gibney, Geoffrey T ; Luke, Jason J ; Thomas, Sajeve ; Buchbinder, Elizabeth I ; Healy, Jane A ; Huang, Mo ; Morrissey, Manju ; Feldman, Igor ; Sehgal, Vasudha ; Robert-Tissot, Celine ; Hou, Peijie ; Zhu, Lili ; Brown, Michelle ; Aanur, Praveen ; Meehan, Robert S ; Zaks, Tal
Source
In The Lancet 17-23 February 2024 403(10427):632-644
Subject
Primary Research Articles
Language
ISSN
0140-6736